Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver‐related mortality
暂无分享,去创建一个
H. Makhlouf | Z. Goodman | M. Stepanova | Z. Younossi | Zachary Goodman | Maria Stepanova | Nila Rafiq | Zobair M Younossi | Hala Makhlouf | Nila Rafiq | Ritambhara Agrawal | Zahra Younoszai | R. Agrawal | Z. Younoszai | Zahra Younoszai
[1] J. Marrero,et al. NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States , 2002, Hepatology.
[2] S. Harrison,et al. Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection , 2010, Hepatology.
[3] J. Goldblum,et al. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[4] Z. Younossi,et al. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. , 2008, Journal of hepatology.
[5] I. Wanless,et al. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors , 1990, Hepatology.
[6] M. Bennett,et al. The natural history of nonalcoholic fatty liver: A follow‐up study , 1995, Hepatology.
[7] Z. Goodman,et al. Predictors of Nonalcoholic Steatohepatitis and Advanced Fibrosis in Morbidly Obese Patients , 2005, Obesity surgery.
[8] G. Zoppini,et al. Risk of all-cause and cardiovascular mortality in patients with chronic liver disease , 2010, Gut.
[9] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[10] Z. Younossi,et al. 6 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH HIGHER OVERALL MORTALITY AND LIVER RELATED MORTALITY , 2008 .
[11] Z. Younossi,et al. Erratum: Nonalcoholic fatty liver disease in patients with type 2 diabetes (Clinical Gastroenterology and Hepatology (2004) 2 (262-265)) , 2004 .
[12] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.
[13] J. Ludwig,et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.
[14] Z. Younossi,et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.
[15] G. Marchesini,et al. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? , 2008, Diabetologia.
[16] Z. Younossi,et al. Epidemiology and natural history of NAFLD and NASH. , 2007, Clinics in liver disease.
[17] Z. Goodman,et al. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[18] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[19] G. Targher,et al. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. , 2007, Atherosclerosis.
[20] M. Stepanova,et al. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study , 2010, Gut.
[21] Z. Younossi,et al. Nonalcoholic fatty liver disease in patients with type 2 diabetes. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[22] Z. Younossi,et al. Nonalcoholic fatty liver disease: a practical approach to evaluation and management. , 2009, Clinics in liver disease.
[23] G. Musso,et al. Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity , 2011, Annals of medicine.
[24] K. Tokushige,et al. Prevalence, gender, ethnic variations, and prognosis of NASH , 2011, Journal of Gastroenterology.
[25] R. Xu,et al. Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study , 2008, The American Journal of Gastroenterology.
[26] Greger Lindberg,et al. Decreased survival of subjects with elevated liver function tests during a 28‐year follow‐up , 2010, Hepatology.
[27] B. Neuschwander‐Tetri,et al. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings , 2011, Hepatology.
[28] Chunhong Bai,et al. Long-term follow-up of patients with nonalcoholic fatty liver. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[29] S. Sanderson,et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. , 2005, Journal of hepatology.
[30] M. Holmqvist,et al. Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.
[31] B. Neuschwander‐Tetri,et al. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease , 2010, Hepatology.